A staging system based on genetic markers could facilitate the stratification and prognostication of intracranial ependymomas, according to research published in the Journal of Clinical Oncology.
Ependymoma arise from ependymal cells. These cells produce cerebrospinal fluid that protects the brain and spinal cord. Ependymoma presents as headaches, nausea, vomiting, dizziness. Ependymoma of ...